US Stock MarketDetailed Quotes

NUS Nu Skin Enterprises

Watchlist
  • 7.960
  • +0.070+0.89%
Close Feb 27 16:00 ET
  • 8.030
  • +0.070+0.88%
Post 20:01 ET
395.79MMarket Cap-2.70P/E (TTM)

Nu Skin Enterprises Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.81%111.74M
-52.40%25.79M
-38.40%31.43M
44.16%51.21M
115.03%3.32M
9.79%118.64M
112.21%54.17M
79.41%51.03M
-23.70%35.52M
-392.76%-22.08M
Net income from continuing operations
-1,805.57%-146.59M
-595.81%-36.11M
122.47%8.3M
-539.75%-118.26M
-104.69%-533K
-91.80%8.6M
-87.27%7.28M
-45.55%-36.96M
-21.45%26.89M
-70.62%11.38M
Operating gains losses
-10.67%1.63M
-126.95%-276K
-109.62%-181K
-78.22%225K
187.64%1.86M
-78.03%1.82M
61.77%1.02M
-29.39%1.88M
-74.77%1.03M
-338.90%-2.12M
Depreciation and amortization
-1.57%69.81M
-11.49%16.45M
-4.79%17.32M
2.56%17.6M
8.56%18.44M
-2.18%70.92M
0.07%18.58M
0.12%18.19M
-7.89%17.16M
-0.86%16.98M
Deferred tax
-206.67%-55.48M
-489.24%-47.85M
52.24%-5.31M
-399.43%-3.66M
1,972.22%1.35M
64.96%-18.09M
84.99%-8.12M
-489.61%-11.12M
13.56%1.22M
-102.19%-72K
Other non cash items
-20.17%26.6M
-64.62%2.96M
5.09%8.88M
-14.76%6.78M
-6.76%7.99M
-25.15%33.32M
-25.86%8.35M
-25.08%8.45M
-30.19%7.96M
-19.04%8.57M
Change In working capital
65.31%-28.34M
-46.91%10.33M
-55.40%-2.65M
88.70%-4M
50.03%-32.02M
39.92%-81.68M
217.77%19.46M
93.77%-1.7M
-41.97%-35.36M
4.63%-64.08M
-Change in receivables
65.77%-7.76M
-349.26%-12.84M
167.39%3.68M
13.92%-6.05M
148.56%7.45M
-98.09%-22.68M
26.41%5.15M
36.48%-5.46M
-227.00%-7.03M
-23.05%-15.34M
-Change in inventory
329.30%30.32M
-57.65%5.37M
-73.64%2.01M
251.31%15.94M
130.43%7M
-344.89%-13.22M
193.70%12.68M
135.25%7.63M
-170.22%-10.53M
-233.63%-23M
-Change in prepaid assets
-90.89%579K
920.31%21.75M
-70.68%4.8M
-1,771.66%-12.62M
-3.54%-13.35M
130.57%6.36M
-77.70%2.13M
52.59%16.37M
29.50%755K
28.80%-12.9M
-Change in payables and accrued expense
27.01%-34.88M
-9,514.55%-5.29M
36.81%-12.76M
89.27%-2.03M
-71.64%-14.8M
57.17%-47.78M
99.62%-55K
-102.19%-20.19M
54.13%-18.92M
81.22%-8.62M
-Change in other current assets
-2,442.22%-1.05M
530.40%3.01M
-95.26%108K
106.83%126K
-397.11%-4.3M
-98.55%45K
109.67%477K
-36.20%2.28M
-152.41%-1.85M
-191.82%-864K
-Change in other current liabilities
-253.00%-15.54M
-81.26%-1.67M
78.98%-490K
-70.89%644K
-317.26%-14.02M
72.19%-4.4M
-133.88%-923K
-66.62%-2.33M
126.61%2.21M
61.99%-3.36M
Cash from discontinued investing activities
Operating cash flow
-5.81%111.74M
-52.40%25.79M
-38.40%31.43M
44.16%51.21M
115.03%3.32M
9.79%118.64M
112.21%54.17M
79.41%51.03M
-23.70%35.52M
-392.76%-22.08M
Investing cash flow
Cash flow from continuing investing activities
71.78%-37.96M
11.53%-13.62M
45.01%-6.55M
90.78%-8.53M
36.98%-9.26M
-100.51%-134.5M
-15.04%-15.4M
52.77%-11.91M
-404.09%-92.5M
-45.03%-14.7M
Net PPE purchase and sale
28.91%-41.58M
38.27%-12.58M
27.80%-8.6M
44.79%-8.12M
-6.91%-12.28M
0.96%-58.49M
-47.91%-20.39M
53.23%-11.91M
-54.23%-14.71M
-11.75%-11.49M
Net business purchase and sale
--0
--0
--0
----
----
---77.28M
--0
--0
----
----
Net investment purchase and sale
186.47%3.62M
-120.83%-1.04M
--2.05M
20.62%-408K
194.08%3.02M
115.75%1.26M
1,156.17%4.99M
--0
94.17%-514K
-2,297.95%-3.21M
Cash from discontinued investing activities
Investing cash flow
71.78%-37.96M
11.53%-13.62M
45.01%-6.55M
90.78%-8.53M
36.98%-9.26M
-100.51%-134.5M
-15.04%-15.4M
52.77%-11.91M
-404.09%-92.5M
-45.03%-14.7M
Financing cash flow
Cash flow from continuing financing activities
-1,341.16%-133.18M
-115.28%-43.63M
25.01%-28.78M
-142.38%-28.82M
-2,415.58%-31.96M
110.78%10.73M
60.10%-20.27M
37.20%-38.37M
47.30%67.99M
104.09%1.38M
Net issuance payments of debt
-216.62%-112.89M
-4,873.53%-40.58M
-341.09%-25.74M
-129.67%-25.78M
-225.30%-20.79M
278.41%96.8M
96.45%-816K
-96.23%-5.84M
45.87%86.87M
307.97%16.59M
Net common stock issuance
--0
--0
----
----
----
81.42%-13.01M
--0
----
----
----
Cash dividends paid
84.63%-11.93M
84.52%-2.98M
84.69%-2.98M
84.69%-2.98M
84.64%-2.98M
-0.79%-77.62M
-1.27%-19.27M
-0.95%-19.49M
-0.43%-19.48M
-0.51%-19.39M
Proceeds from stock option exercised by employees
-145.23%-2.06M
67.22%-59K
-29.27%-53K
-110.03%-60K
-145.20%-1.89M
-83.14%4.56M
-114.31%-180K
-103.43%-41K
-97.16%598K
19.00%4.18M
Net other financing activities
---6.3M
--0
--0
--0
---6.3M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-1,341.16%-133.18M
-115.28%-43.63M
25.01%-28.78M
-142.38%-28.82M
-2,415.58%-31.96M
110.78%10.73M
60.10%-20.27M
37.20%-38.37M
47.30%67.99M
104.09%1.38M
Net cash flow
Beginning cash position
-3.27%256.06M
-2.38%227.75M
-4.80%224.25M
-7.57%212.53M
-3.27%256.06M
-22.05%264.73M
-20.68%233.31M
-35.27%235.55M
-23.92%229.94M
-22.05%264.73M
Current changes in cash
-1,057.37%-59.4M
-270.03%-31.46M
-621.15%-3.89M
25.88%13.86M
-7.08%-37.9M
91.23%-5.13M
147.87%18.5M
101.29%747K
-85.19%11.01M
2.64%-35.39M
Effect of exchange rate changes
-176.53%-9.78M
-321.87%-9.41M
347.54%7.39M
60.33%-2.14M
-1,023.81%-5.63M
78.37%-3.54M
-54.14%4.24M
74.92%-2.99M
57.36%-5.4M
159.36%609K
End cash Position
-27.02%186.88M
-27.02%186.88M
-2.38%227.75M
-4.80%224.25M
-7.57%212.53M
-3.27%256.06M
-3.27%256.06M
-20.68%233.31M
-35.27%235.55M
-23.92%229.94M
Free cash flow
16.64%70.16M
-60.92%13.2M
-41.63%22.84M
107.04%43.08M
73.30%-8.96M
22.74%60.15M
187.68%33.78M
1,210.59%39.12M
-43.78%20.81M
-1,125.86%-33.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.81%111.74M-52.40%25.79M-38.40%31.43M44.16%51.21M115.03%3.32M9.79%118.64M112.21%54.17M79.41%51.03M-23.70%35.52M-392.76%-22.08M
Net income from continuing operations -1,805.57%-146.59M-595.81%-36.11M122.47%8.3M-539.75%-118.26M-104.69%-533K-91.80%8.6M-87.27%7.28M-45.55%-36.96M-21.45%26.89M-70.62%11.38M
Operating gains losses -10.67%1.63M-126.95%-276K-109.62%-181K-78.22%225K187.64%1.86M-78.03%1.82M61.77%1.02M-29.39%1.88M-74.77%1.03M-338.90%-2.12M
Depreciation and amortization -1.57%69.81M-11.49%16.45M-4.79%17.32M2.56%17.6M8.56%18.44M-2.18%70.92M0.07%18.58M0.12%18.19M-7.89%17.16M-0.86%16.98M
Deferred tax -206.67%-55.48M-489.24%-47.85M52.24%-5.31M-399.43%-3.66M1,972.22%1.35M64.96%-18.09M84.99%-8.12M-489.61%-11.12M13.56%1.22M-102.19%-72K
Other non cash items -20.17%26.6M-64.62%2.96M5.09%8.88M-14.76%6.78M-6.76%7.99M-25.15%33.32M-25.86%8.35M-25.08%8.45M-30.19%7.96M-19.04%8.57M
Change In working capital 65.31%-28.34M-46.91%10.33M-55.40%-2.65M88.70%-4M50.03%-32.02M39.92%-81.68M217.77%19.46M93.77%-1.7M-41.97%-35.36M4.63%-64.08M
-Change in receivables 65.77%-7.76M-349.26%-12.84M167.39%3.68M13.92%-6.05M148.56%7.45M-98.09%-22.68M26.41%5.15M36.48%-5.46M-227.00%-7.03M-23.05%-15.34M
-Change in inventory 329.30%30.32M-57.65%5.37M-73.64%2.01M251.31%15.94M130.43%7M-344.89%-13.22M193.70%12.68M135.25%7.63M-170.22%-10.53M-233.63%-23M
-Change in prepaid assets -90.89%579K920.31%21.75M-70.68%4.8M-1,771.66%-12.62M-3.54%-13.35M130.57%6.36M-77.70%2.13M52.59%16.37M29.50%755K28.80%-12.9M
-Change in payables and accrued expense 27.01%-34.88M-9,514.55%-5.29M36.81%-12.76M89.27%-2.03M-71.64%-14.8M57.17%-47.78M99.62%-55K-102.19%-20.19M54.13%-18.92M81.22%-8.62M
-Change in other current assets -2,442.22%-1.05M530.40%3.01M-95.26%108K106.83%126K-397.11%-4.3M-98.55%45K109.67%477K-36.20%2.28M-152.41%-1.85M-191.82%-864K
-Change in other current liabilities -253.00%-15.54M-81.26%-1.67M78.98%-490K-70.89%644K-317.26%-14.02M72.19%-4.4M-133.88%-923K-66.62%-2.33M126.61%2.21M61.99%-3.36M
Cash from discontinued investing activities
Operating cash flow -5.81%111.74M-52.40%25.79M-38.40%31.43M44.16%51.21M115.03%3.32M9.79%118.64M112.21%54.17M79.41%51.03M-23.70%35.52M-392.76%-22.08M
Investing cash flow
Cash flow from continuing investing activities 71.78%-37.96M11.53%-13.62M45.01%-6.55M90.78%-8.53M36.98%-9.26M-100.51%-134.5M-15.04%-15.4M52.77%-11.91M-404.09%-92.5M-45.03%-14.7M
Net PPE purchase and sale 28.91%-41.58M38.27%-12.58M27.80%-8.6M44.79%-8.12M-6.91%-12.28M0.96%-58.49M-47.91%-20.39M53.23%-11.91M-54.23%-14.71M-11.75%-11.49M
Net business purchase and sale --0--0--0-----------77.28M--0--0--------
Net investment purchase and sale 186.47%3.62M-120.83%-1.04M--2.05M20.62%-408K194.08%3.02M115.75%1.26M1,156.17%4.99M--094.17%-514K-2,297.95%-3.21M
Cash from discontinued investing activities
Investing cash flow 71.78%-37.96M11.53%-13.62M45.01%-6.55M90.78%-8.53M36.98%-9.26M-100.51%-134.5M-15.04%-15.4M52.77%-11.91M-404.09%-92.5M-45.03%-14.7M
Financing cash flow
Cash flow from continuing financing activities -1,341.16%-133.18M-115.28%-43.63M25.01%-28.78M-142.38%-28.82M-2,415.58%-31.96M110.78%10.73M60.10%-20.27M37.20%-38.37M47.30%67.99M104.09%1.38M
Net issuance payments of debt -216.62%-112.89M-4,873.53%-40.58M-341.09%-25.74M-129.67%-25.78M-225.30%-20.79M278.41%96.8M96.45%-816K-96.23%-5.84M45.87%86.87M307.97%16.59M
Net common stock issuance --0--0------------81.42%-13.01M--0------------
Cash dividends paid 84.63%-11.93M84.52%-2.98M84.69%-2.98M84.69%-2.98M84.64%-2.98M-0.79%-77.62M-1.27%-19.27M-0.95%-19.49M-0.43%-19.48M-0.51%-19.39M
Proceeds from stock option exercised by employees -145.23%-2.06M67.22%-59K-29.27%-53K-110.03%-60K-145.20%-1.89M-83.14%4.56M-114.31%-180K-103.43%-41K-97.16%598K19.00%4.18M
Net other financing activities ---6.3M--0--0--0---6.3M--------------------
Cash from discontinued financing activities
Financing cash flow -1,341.16%-133.18M-115.28%-43.63M25.01%-28.78M-142.38%-28.82M-2,415.58%-31.96M110.78%10.73M60.10%-20.27M37.20%-38.37M47.30%67.99M104.09%1.38M
Net cash flow
Beginning cash position -3.27%256.06M-2.38%227.75M-4.80%224.25M-7.57%212.53M-3.27%256.06M-22.05%264.73M-20.68%233.31M-35.27%235.55M-23.92%229.94M-22.05%264.73M
Current changes in cash -1,057.37%-59.4M-270.03%-31.46M-621.15%-3.89M25.88%13.86M-7.08%-37.9M91.23%-5.13M147.87%18.5M101.29%747K-85.19%11.01M2.64%-35.39M
Effect of exchange rate changes -176.53%-9.78M-321.87%-9.41M347.54%7.39M60.33%-2.14M-1,023.81%-5.63M78.37%-3.54M-54.14%4.24M74.92%-2.99M57.36%-5.4M159.36%609K
End cash Position -27.02%186.88M-27.02%186.88M-2.38%227.75M-4.80%224.25M-7.57%212.53M-3.27%256.06M-3.27%256.06M-20.68%233.31M-35.27%235.55M-23.92%229.94M
Free cash flow 16.64%70.16M-60.92%13.2M-41.63%22.84M107.04%43.08M73.30%-8.96M22.74%60.15M187.68%33.78M1,210.59%39.12M-43.78%20.81M-1,125.86%-33.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
+21.48%
Collegium Pharmaceutical
COLL
+0.25%
SilverCrest Metals
SILV
0.00%
Enerpac Tool
EPAC
-0.20%
Halozyme Therapeutics
HALO
-0.38%

Unlock the Full List